Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use
This successful substitution was further validated using an independent iPSC line
Lifestyle is the key variable: busy people appreciate a quick appointment and no downtime
32 Suppression of MTHFD2 disturbs redox homeostasis, accelerates cell death in both colorectal cancer (CRC), 74,75 and acute myeloid leukemia (AML)
US$ 21.71
US$ 25.20
US$ 24.58
US$ 24.11
US$ 23.56
